Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024
Abstract Background Xylazine has emerged as a major component of the unregulated opioid supply in several jurisdictions across the United States. However, the extent of xylazine in local drug supplies is unknown. Drug checking is a harm reduction strategy that provides information to people who use...
Saved in:
| Main Authors: | Leonardo A. Dominguez Gomez, Yarelix Estrada, Jeffery Sauer, Izza Zaidi, Andrew J. Trinidad, Hannah Helmy, Alex Harocopos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Harm Reduction Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12954-025-01237-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opioid‐related xylazine toxicity manifesting as myonecrosis, rhabdomyolysis, multifocal ischemic cerebral infarcts, and cerebral edema
by: Ogechi Nwodim, et al.
Published: (2024-06-01) -
Using RE-AIM to evaluate the implementation of a social marketing and free product distribution project for fentanyl and xylazine test strips in New York State
by: Hilary M. Kirk, et al.
Published: (2025-06-01) -
Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market
by: Rachel Sutherland, et al.
Published: (2025-05-01) -
Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant
by: Kory S. London, et al.
Published: (2025-05-01) -
“Anything can happen”: experiences of people using opioids in a xylazine market
by: Megan K. Reed, et al.
Published: (2025-07-01)